Abstract
Context: The molecular bases of adrenocortical tumors (ACT) are only partially established. Changes in antioxidant defense mechanisms have been associated with increased risk of several types of cancer. Dysregulation of this system may also be associated with tumor growth, metastasis, and drug resistance. However, little data shows how oxidative stress-related biomarkers are involved in t…